Healthcare Global Enterprises Limited
Healthcare Global Enterprises Ltd is engaged in setting up and managing hospitals and medical diagnostic services including scientific testing and consultancy services in the pharmaceutical and medical sector.
What Healthcare files
- Others94
- Investor Meet28
- Important24
- Updates21
- Board Meeting14
- PPTs10
HCG has scheduled its 28th AGM virtually. The company ensures access to the AGM notice and FY25-26 Annual Report via web links and QR codes, particularly for shareholders without registered email addresses.
HCG's revenue climbed 13% YoY to 695.1 Cr; Adjusted EBITDA jumped 20% to 133.9 Cr, and PAT surged 190%. Key operational changes include 121 new beds, a new North Bangalore hospital, and the divestment of its Fertility Business.
HCG's board approved a fresh investment of up to ₹16 Cr into its wholly-owned subsidiary, HCG Rajkot Hospitals LLP. This funding for the 147-bed cancer hospital, with FY26 revenue of ₹60.67 Cr, is earmarked for debt repayment, working capital, and general corporate purposes.
HealthCare Global Enterprises completed the divestment of its entire stake in BACC Health Care for 37.64 Cr. An initial 28.23 Cr has been received, with the balance deferred consideration due in 18 months.
HealthCare Global (HCG) posted strong annual results: Revenue grew 15% to 2,545.4 Cr, EBITDA jumped 19% to 471.1 Cr. Quarterly performance also robust. A 425 Cr rights issue strengthens finances, backing expansion and advanced oncology tech.